ID: ALA5076101

Max Phase: Preclinical

Molecular Formula: C24H32FN5O2

Molecular Weight: 441.55

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2nc(NCCCN(C)C)ncc2c1

Standard InChI:  InChI=1S/C24H32FN5O2/c1-5-16-11-22(32)20(25)12-19(16)17-9-18-13-27-24(26-7-6-8-30(3)4)29-23(18)21(10-17)28-15(2)14-31/h9-13,15,28,31-32H,5-8,14H2,1-4H3,(H,26,27,29)/t15-/m0/s1

Standard InChI Key:  WAUZCJHXYOESCD-HNNXBMFYSA-N

Associated Targets(Human)

Serine/threonine-protein kinase Aurora-B 6805 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase JAK1 8569 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase JAK2 12915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase JAK3 8349 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase TYK2 5029 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vascular endothelial growth factor receptor 2 20924 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

JAK3/JAK1 270 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

JAK1/JAK2/TYK2 47 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 441.55Molecular Weight (Monoisotopic): 441.2540AlogP: 3.86#Rotatable Bonds: 10
Polar Surface Area: 93.54Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.38CX Basic pKa: 9.44CX LogP: 2.25CX LogD: 1.43
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.36Np Likeness Score: -0.64

References

1. Wellaway CR, Baldwin IR, Bamborough P, Barker D, Bartholomew MA, Chung CW, Dümpelfeld B, Evans JP, Fazakerley NJ, Homes P, Keeling SP, Lewell XQ, McNab FW, Morley J, Needham D, Neu M, van Oosterhout AJM, Pal A, Reinhard FBM, Rianjongdee F, Robertson CM, Rowland P, Shah RR, Sherriff EB, Sloan LA, Teague S, Thomas DA, Wellaway N, Wojno-Picon J, Woolven JM, Coe DM..  (2022)  Investigation of Janus Kinase (JAK) Inhibitors for Lung Delivery and the Importance of Aldehyde Oxidase Metabolism.,  65  (1.0): [PMID:34928601] [10.1021/acs.jmedchem.1c01765]

Source